Oncology Clinical Trials in Fort Wayne, IN
As of September 2026, 46 paid clinical trials are recruiting for Oncology in Fort Wayne, Indiana. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
46 clinical trials for Oncology
·Clear filters·A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
A Study of HS-20110 in Participants With Advanced Solid Tumors
BostonGene and Exigent Genomic INsight Study
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Integrated Cancer Repository for Cancer Research
Top Research Study Locations in Fort Wayne
Researchers run research studies in Fort Wayne, IN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Fort Wayne Medical Oncology and Hematology | Breast Cancer, Mantle Cell Lymphoma, Melanoma | 18 |
| Parkview Research Center | Endometrial Cancer, Ovarian Cancer, Prostate Cancer | 13 |
| Parkview Regional Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 8 |
| Parkview Research Center at Parkview Regional Medical Center | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Carcinoma, Transitional Cell | 8 |
| Parkview Health | Aortic Stenosis, Breast Cancer, Coronary Artery Disease | 4 |
| Fort Wayne Medical Oncology and Hematology, Inc | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 3 |
| Orthopaedics Northeast | Intra-facet ION 3D Facet Screw System, OsteoFlo HydroFiber, Degenerative Disc Disease | 3 |
| Fort Wayne Neurological Center | Cataplexy, EDS, Fatigue | 2 |
| GSK Investigational Site | Neoplasms, Neoplasms, Head and Neck | 2 |
| Lutheran Medical Group | Arteriovenous Fistula, Catheter Complications, Catheter Dysfunction | 2 |
| NexGen Research | Alzheimer Disease, Heart Failure | 2 |
| Parkview Cancer Institute | Chemo Fog, Chemo-brain, Chemotherapy Effect | 2 |
| Parkview Packnett Family Cancer Institute | Metastatic Bone Disease, Metastatic Non-small Cell Lung Cancer | 2 |
| Salus Research, Inc. | Gingivitis, Dental Plaque, Gingival Bleeding | 2 |
| American Oncology Partners | B-cell Malignancy, Chronic Lymphocytic Leukemia, Follicular Lymphoma | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Dupont Hospital | Cartilage Damage, Cartilage Defects of the Knee, Cartilage Lesion | 1 |
| Ep0162 50504 | Stereotypical Prolonged Seizures | 1 |
| Ep0165 50504 | Stereotypical Prolonged Seizures | 1 |
| Fort Wayne Center for Children and Families | Conflict, Mental Health | 1 |
| Fort Wayne Medical Oncology & Hematology | Colorectal Neoplasms | 1 |
| Fort Wayne Medical Oncology Hematology | Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | 1 |
| Fort Wayne Medical Oncology and Hematology, Inc. | Non-small Cell Lung Cancer | 1 |
| Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office | Neuroendocrine Carcinomas, Small-cell Lung Cancer, Solid Tumor Show to Express DLL3 | 1 |
| Fort Wayne Oncology and Hematology | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | 1 |
Active & Upcoming Studies in Fort Wayne (2026)
Recruiting trials in Fort Wayne grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (64 active studies)
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease · Phase 3 · BeOne Medicines
- Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) · Phase 3 · Astellas Pharma Global Development, Inc.
Cardiovascular (4 active studies)
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) · Phase 2 · Pfizer
- Prevail Global Study · Medtronic Vascular
Neurology & pain (3 active studies)
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 · Phase 3 · Rapport Therapeutics Inc.
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) · Phase 4 · Alpha Cognition, Inc
Common conditions studied in Fort Wayne
- Breast Cancer (6 active studies)
- Endometrial Cancer (5 active studies)
- Ovarian Cancer (5 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Non-small Cell Lung Cancer (4 active studies)
- Chronic Lymphocytic Leukemia (3 active studies)
Leading research sponsors in Fort Wayne
- Merck Sharp & Dohme LLC
- AbbVie
- AstraZeneca
- BeOne Medicines
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Fort Wayne?
There are approximately 106 recruiting clinical trials in Fort Wayne, Indiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fort Wayne pay participants?
Most recruiting trials in Fort Wayne compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fort Wayne?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fort Wayne?
The most common conditions under active study in Fort Wayne include Breast Cancer (6), Endometrial Cancer (5), Ovarian Cancer (5), Carcinoma, Non-Small-Cell Lung (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fort Wayne?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fort Wayne on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fort Wayne?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fort Wayne?
Recruiting research sites in Fort Wayne include Fort Wayne Medical Oncology and Hematology, Parkview Research Center, Parkview Regional Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fort Wayne right now?
The largest active categories in Fort Wayne are Cancer & tumors (64), Cardiovascular (4), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.